WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
BCRX
BIOCRYST PHARMACEUTICALS INC
$4.57N/AN/A-3.87x-28.56x2.65x-2.07xN/A-$97.31M-11.07%-$455.53M-2.37$1.68B-14.43
THRD
THIRD HARMONIC BIO INC
$11.38N/AN/A-14.59xN/AN/A1.72xN/A-$20.59M-4.56%$269.09M6.79$197.76M-6.54
GPCR
STRUCTURE THERAPEUTICS INC
$39.32N/AN/A-16.18xN/AN/A4.04xN/A-$81.66M-5.65%$452.97M12.33$1.71B-19.29
DSGN
DESIGN THERAPEUTICS INC
$3.62N/AN/A-3.04x-2.17xN/A0.74xN/A-$58.82M-29.03%$277.69M4.96$185.64M-2.80
ABOS
ACUMEN PHARMACEUTICALS INC
$3.25N/AN/A-3.01x-2.83xN/A0.73xN/A-$43.08M-27.26%$266.97M5.49$159.19M-3.08
CNTB
CONNECT BIOPHARMA HOLDINGS LTD
$1.43N/AN/A-1.32x-0.63xN/A0.78xN/A-$45.28M-57.48%$101.04M1.83-$26.74M0.45
MACK
MERRIMACK PHARMACEUTICALS INC
$14.98N/AN/A-187.25xN/AN/A11.60xN/A-$1.52M-0.71%$18.75M1.31$211.46M-180.89
CDTX
CIDARA THERAPEUTICS INC
$11.81N/AN/A-2.27x-1.97x0.81x-6.56xN/A-$22.94M-44.43%-$8.21M-1.88$22.97M-1.08
CELC
CELCUITY INC
$16.30N/AN/A-6.06x-7.38xN/A3.55xN/A-$53.91M-13.97%$139.77M5.90$503.17M-8.63
IPA
IMMUNOPRECISE ANTIBODIES LTD
$1.25N/AN/A-3.03xN/A1.85x0.90xN/A-$3.36M-10.40%$36.63M1.42$38.85M-5.51
NUVB
NUVATION BIO INC
$3.20N/AN/A-9.14x-5.61xN/A1.16xN/A-$68.05M-9.72%$605.12M2.77$662.31M-8.76
SNPX
SYNAPTOGENIX INC
$4.83N/AN/A-0.16xN/AN/A0.22xN/A-$5.18M-229.92%$24.35M52.24-$23.42M3.88
SYRS
SYROS PHARMACEUTICALS INC
$5.44N/AN/A-0.94x-0.58x15.50x8.64xN/A-$108.42M-70.37%$16.66M0.59$64.34M-0.41
PTIX
PROTAGENIC THERAPEUTICS INC
$1.30N/AN/A-1.13xN/AN/A1.57xN/A-$3.85M-68.23%$3.67M0.84$4.48M-0.92
SCPH
SCPHARMACEUTICALS INC
$4.54N/AN/A-3.20x-4.13x12.86x4.40xN/A-$59.28M-33.90%$37.22M0.97$157.14M-3.41
INMB
INMUNE BIO INC
$11.60N/AN/A-6.95x-5.66x1,288.89x5.60xN/A-$11.98M-5.74%$37.34M2.08$183.70M-6.12
APLS
APELLIS PHARMACEUTICALS INC
$46.05N/AN/A-10.35x-73.10x13.78x28.55xN/A-$595.41M-10.89%$194.52M1.64$5.31B-10.73
IOVA
IOVANCE BIOTHERAPEUTICS INC
$12.50N/AN/A-6.61x-12.25x2,500.00x5.97xN/A-$384.11M-13.07%$584.61M2.49$3.39B-8.17
MTNB
MATINAS BIOPHARMA HOLDINGS INC
$0.18N/AN/A-1.66xN/A36.60x2.07xN/A-$15.50M-38.80%$19.25M0.09$38.57M-1.75
AFMD
AFFIMED NV
$5.33N/AN/A-0.69x-0.89x8.85x1.29xN/A-$123.91M-155.59%$62.83M4.21$60.32M-0.53
GNLX
GENELUX CORP
$3.28N/AN/A-2.83xN/A468.57x4.53xN/A-$21.30M-26.59%$19.47M0.80$80.57M-2.92
ORGS
ORGENESIS INC
$0.53$11.42-95.39%0.28xN/A29.22x-0.86x0.20x-$16.93M-111.03%-$20.98M-0.72$39.20M-0.77
TNGX
TANGO THERAPEUTICS INC
$7.28N/AN/A-6.74x-3.35x18.86x3.07xN/A-$119.51M-17.36%$253.11M2.68$748.59M-7.83
RCUS
ARCUS BIOSCIENCES INC
$15.50N/AN/A-3.73x-3.87x9.80x3.05xN/A-$330.00M-28.77%$462.00M6.24$1.28B-4.50
CTMX
CYTOMX THERAPEUTICS INC
$5.13N/AN/A-513.00x-9.68x3.74x-7.32xN/A-$56.88M-15.03%-$47.45M-0.64$343.30M37.21
PRAX
PRAXIS PRECISION MEDICINES INC
$55.16N/AN/A-2.95x-1.30x148.68x10.48xN/A-$111.19M-30.57%$69.67M10.57$651.42M-5.34
ONVO
ORGANOVO HOLDINGS INC
$0.93N/AN/A-0.43xN/A34.48x1.51xN/A-$16.92M-199.36%$6.18M0.68$5.41M-0.29
NTRB
NUTRIBAND INC
$3.50N/AN/A-5.07xN/A13.36x5.96xN/A-$3.58M-12.86%$6.44M0.81$38.14M-7.49
MGX
METAGENOMI INC
$7.04N/AN/A-0.35xN/A0.54x-1.95xN/A-$101.22M-422.32%-$135.58M-39.82$166.18M-3.21
IBRX
IMMUNITYBIO INC
$8.54N/AN/A-7.43x-10.81x8,540.00x-9.81xN/A-$397.34M-9.15%-$586.99M-1.15$6.37B-14.84
FTRE
FORTREA HOLDINGS INC
$37.14N/AN/A-928.50xN/A1.07x1.91xN/A$135.60M4.08%$1.74B19.45$4.89B25.11
PRQR
PROQR THERAPEUTICS NV
$2.00N/AN/A-5.26x-2.86x15.63x3.62xN/A$30.63M18.90%$44.99M0.56$54.89M-2.08
ELAB
ELEVAI LABS INC
$0.65N/AN/A-1.63xN/A4.10x2.95xN/A-$4.57M-65.18%$3.83M0.36$8.18M-1.92
PHAT
PHATHOM PHARMACEUTICALS INC
$9.26N/AN/A-2.36x-2.73x712.31x-7.44xN/A-$139.21M-29.31%-$72.76M-1.42$596.09M-3.75
OABI
OMNIAB INC
$4.56N/AN/A-8.94xN/A13.29x1.70xN/A$703.00k0.15%$314.59M3.16$542.74M-12.10
SYBX
SYNLOGIC INC
$1.90N/AN/A-0.22x-0.18x3.67x0.52xN/A-$51.81M-419.37%$42.66M6.56$14.35M-0.28
FBIO
FORTRESS BIOTECH INC
$1.74N/AN/A-0.21x0.08x0.17x1.48xN/A-$122.29M-866.49%$22.54M2.78$35.70M-0.97
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
$1.21N/AN/A-2.24x-0.94x4.03x7.57xN/A-$145.56M-59.83%$39.51M0.20$177.47M-1.73
CDXC
CHROMADEX CORP
$3.66N/AN/A-52.29x-61.00x3.29x9.69xN/A$6.97M2.54%$28.46M0.38$251.58M-77.82
AUTL
AUTOLUS THERAPEUTICS PLC
$4.00N/AN/A-3.33x-3.33x400.00x9.54xN/A-$156.57M-22.50%$111.47M0.64$1.05B-6.86
HRTX
HERON THERAPEUTICS INC
$2.34N/AN/A-2.93x-46.80x2.54x-10.35xN/A-$60.32M-18.68%-$33.97M-0.25$502.72M-4.69
LEXX
LEXARIA BIOSCIENCE CORP
$3.49N/AN/A-5.13x-4.01x96.94x6.90xN/A-$5.21M-13.87%$6.52M0.61$40.41M-7.72
OLMA
OLEMA PHARMACEUTICALS INC
$10.40N/AN/A-4.86x-3.30xN/A2.29xN/A-$83.71M-17.79%$253.90M5.61$515.39M-5.43
HEPA
HEPION PHARMACEUTICALS INC
$1.36N/AN/A-0.11x-0.11xN/A1.02xN/A-$40.90M-757.43%$7.28M1.83-$7.13M0.14
CRVS
CORVUS PHARMACEUTICALS INC
$1.61N/AN/A-2.88x-1.04xN/A2.04xN/A-$23.97M-30.99%$38.68M0.81$67.71M-2.52
ATXI
AVENUE THERAPEUTICS INC
$4.76N/AN/A-0.06xN/AN/A1.78xN/A-$9.45M-1,405.95%$1.58M11.20$1.03M-0.10
SRZN
SURROZEN INC
$9.89N/AN/A-0.46x-0.52xN/A0.83xN/A-$40.76M-204.24%$37.94M18.80-$1.72M0.04
VIGL
VIGIL NEUROSCIENCE INC
$2.65N/AN/A-1.24x-0.81xN/A0.84xN/A-$71.04M-69.25%$116.25M3.00$58.68M-0.73
NNVC
NANOVIRICIDES INC
$1.13N/AN/A-1.40xN/AN/A1.07xN/A-$6.20M-46.73%$12.45M1.06$8.06M-0.94
THTX
THERATECHNOLOGIES INC
$1.30N/AN/A-3.16x4.06x1.04x-3.30xN/A-$3.05M-5.08%-$18.09M-0.39$79.55M-56.26
RLMD
RELMADA THERAPEUTICS INC
$3.69N/AN/A-1.13x-0.91xN/A1.30xN/A-$51.66M-46.50%$85.36M2.84$107.25M-1.09
IRON
DISC MEDICINE INC
$28.53N/AN/A-8.34x-4.60xN/A2.04xN/A-$73.55M-11.55%$345.12M15.47$345.87M-4.55
ZURA
ZURA BIO LTD
$4.15N/AN/A-1.99xN/AN/A3.05xN/A-$15.05M-10.96%$59.33M1.79$81.11M-1.34
IMVT
IMMUNOVANT INC
$28.52N/AN/A-15.58x-13.84xN/A6.10xN/A-$210.56M-5.11%$679.34M4.70$3.45B-14.23
ALXO
ALX ONCOLOGY HOLDINGS INC
$16.94N/AN/A-4.53x-4.80xN/A4.48xN/A-$131.64M-18.08%$189.71M4.41$836.81M-5.28
APVO
APTEVO THERAPEUTICS INC
$0.96N/AN/A-0.02xN/AN/A0.04xN/A-$11.73M-4,394.27%$12.22M43.95-$10.99M0.65
INTS
INTENSITY THERAPEUTICS INC
$3.85N/AN/A-2.79xN/AN/A4.01xN/A-$7.21M-21.71%$13.16M1.53$44.36M-4.40
ATNM
ACTINIUM PHARMACEUTICALS INC
$7.78N/AN/A-4.55xN/A2,593.33x5.28xN/A-$39.72M-18.30%$43.86M1.57$149.64M-3.28
SGMT
SAGIMET BIOSCIENCES INC
$4.11N/AN/A-1.55xN/A21.52x1.44xN/A-$23.77M-55.28%$91.07M8.71$56.09M-2.02
ADTX
ADITXT INC
$2.41N/AN/A-0.02x0.00x1.13x0.25xN/A-$18.59M-2,551.37%$16.06M53.10$22.03M-0.80
MURA
MURAL ONCOLOGY PLC
$3.78N/AN/A-0.30xN/AN/A0.24xN/A-$197.70M-313.39%$263.82M15.81-$192.13M1.00
COYA
COYA THERAPEUTICS INC
$8.67N/AN/A-10.97xN/A14.67x3.54xN/A-$11.19M-12.70%$35.64M3.51$93.46M-12.91
ACHL
ACHILLES THERAPEUTICS PLC
$0.78N/AN/A-0.45x-0.39xN/A0.23xN/A-$49.55M-158.57%$142.37M3.56-$94.80M1.47
MIRA
MIRA PHARMACEUTICALS INC
$0.82N/AN/A-1.28xN/AN/A2.77xN/A-$4.53M-29.79%$4.37M0.24$7.51M-0.88
ALVR
ALLOVIR INC
$0.81N/AN/A-0.44x-0.36xN/A0.64xN/A-$124.45M-147.65%$145.78M1.40$29.50M-0.16
GOSS
GOSSAMER BIO INC
$0.71N/AN/A-0.60x-0.32xN/A2.54xN/A-$159.16M-147.32%$62.77M0.41$336.77M-2.08
ELDN
ELEDON PHARMACEUTICALS INC
$2.29N/AN/A-1.40x-0.79xN/A0.68xN/A-$39.53M-70.13%$83.42M3.39$52.59M-1.32
EWTX
EDGEWISE THERAPEUTICS INC
$19.01N/AN/A-12.11x-8.64xN/A5.55xN/A-$97.69M-8.06%$318.83M5.00$1.69B-17.16
NMRA
NEUMORA THERAPEUTICS INC
$9.10N/AN/A-2.51xN/AN/A3.08xN/A-$163.40M-27.62%$469.08M7.21$1.08B-4.64
GOVX
GEOVAX LABS INC
$1.45N/AN/A-0.10xN/AN/A0.55xN/A-$25.22M-957.17%$5.76M3.17-$3.30M0.13
SLRN
ACELYRIN INC
$4.25N/AN/A-0.78xN/AN/A0.64xN/A-$172.00M-57.60%$656.34M9.34$201.15M-0.53
INZY
INOZYME PHARMA INC
$4.61N/AN/A-3.36x-2.66xN/A2.03xN/A-$70.97M-29.70%$140.48M2.71$296.46M-4.46
XERS
XERIS BIOPHARMA HOLDINGS INC
$1.75N/AN/A-3.89x-7.61x1.47x-36.24xN/A-$49.29M-20.46%-$6.78M-0.05$407.54M-17.17
TARA
PROTARA THERAPEUTICS INC
$2.93N/AN/A-0.82x-1.26xN/A0.49xN/A-$37.60M-113.24%$68.32M6.03-$617.86k0.02
LXEO
LEXEO THERAPEUTICS INC
$12.30N/AN/A-0.99xN/AN/A2.89xN/A-$59.61M-90.51%$113.54M21.20$214.95M-3.34
CARM
CARISMA THERAPEUTICS INC
$1.63N/AN/A-0.63xN/A3.66x2.55xN/A-$82.31M-150.61%$26.53M0.79-$6.77M0.08
SNTI
SENTI BIOSCIENCES INC
$0.38N/AN/A-0.24xN/A6.55x0.26xN/A-$64.33M-381.58%$66.91M1.51$15.60M-0.24
SRRK
SCHOLAR ROCK HOLDING CORP
$14.96N/AN/A-7.52x-5.65xN/A5.17xN/A-$145.28M-11.65%$225.22M2.70$1.12B-7.20
CRGX
CARGO THERAPEUTICS INC
$20.54N/AN/A-1.24xN/AN/A1.99xN/A-$89.44M-73.32%$405.39M68.26$430.76M-4.64
ATHE
ALTERITY THERAPEUTICS LTD
$2.20N/AN/A-0.98xN/AN/A1.07xN/A-$9.55M-92.91%$11.52M2.47$4.28MN/A
RNAC
CARTESIAN THERAPEUTICS INC
$22.64N/AN/A-0.45x-9.43x4.50x-0.28xN/A-$51.37M-43.88%-$440.18M-85.14$56.26M-0.24
FBRX
FORTE BIOSCIENCES INC
$0.67N/AN/A-0.67x-0.41xN/A0.69xN/A-$28.79M-135.92%$35.31M1.12-$12.70M0.40
DRTS
ALPHA TAU MEDICAL LTD
$2.43N/AN/A-5.79x-3.86xN/A2.00xN/A-$24.36M-14.44%$84.48M1.22$169.92M-7.89
RZLT
REZOLUTE INC
$2.76N/AN/A-2.51x-1.01xN/A1.19xN/A-$53.00M-37.36%$91.73M1.78$99.37M-1.77
ADCT
ADC THERAPEUTICS SA
$4.71N/AN/A-1.60x-2.60x5.53x-2.62xN/A-$121.90M-31.68%-$148.25M-1.81$234.49M-1.55
ONCT
ONCTERNAL THERAPEUTICS INC
$8.25N/AN/A-0.61x-0.48x30.90x0.81xN/A-$32.16M-132.61%$30.05M10.22$18.04M-0.46
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$42.84N/AN/A-58.68x-32.21xN/A5.52xN/A-$43.06M-2.05%$495.68M10.09$2.29B-52.07
TSBX
TURNSTONE BIOLOGICS CORP
$2.60N/AN/A-0.54xN/A1.56x0.61xN/A-$66.95M-222.69%$98.67M8.53$45.36M-0.86
GLTO
GALECTO INC
$0.68N/AN/A-0.60x-0.28xN/A0.65xN/A-$33.63M-182.35%$28.16M1.04-$2.65M0.09
TRML
TOURMALINE BIO INC
$15.71N/AN/A-1.77x-1.02xN/A1.96xN/A-$28.14M-37.73%$205.04M43.19$262.37M-6.25
COGT
COGENT BIOSCIENCES INC
$6.93N/AN/A-2.86x-3.43xN/A2.79xN/A-$156.42M-28.34%$257.80M3.24$685.74M-3.63
REPL
REPLIMUNE GROUP INC
$6.48N/AN/A-2.05x-2.20xN/A0.94xN/A-$176.27M-40.82%$421.54M6.33$374.30M-1.87
VRPX
VIRPAX PHARMACEUTICALS INC
$2.54N/AN/A-0.20xN/AN/A1.54xN/A-$9.85M-331.22%$1.93M1.65-$6.17M0.41
RAPT
RAPT THERAPEUTICS INC
$8.18N/AN/A-2.68x-2.07xN/A1.94xN/A-$98.17M-31.31%$147.04M3.84$244.07M-2.16
RCKT
ROCKET PHARMACEUTICALS INC
$22.53N/AN/A-7.72x-7.72xN/A4.14xN/A-$211.39M-11.17%$492.57M5.86$2.01B-8.48
IVVD
INVIVYD INC
$2.42N/AN/A-1.34x-3.18xN/A1.63xN/A-$173.78M-65.58%$177.47M1.62$90.04M-0.46
ACLX
ARCELLX INC
$52.18N/AN/A-35.50x-20.71x22.74x5.68xN/A$186.15M7.42%$485.38M10.10$2.46B-55.49
VALN
VALNEVA SE
$7.57N/AN/A-4.77x-4.07x3.15x3.77xN/A-$234.38M-44.58%$139.40M2.01$615.71M-7.52
OBIO
ORCHESTRA BIOMED HOLDINGS INC
$4.40N/AN/A-2.97xN/A53.01x2.31xN/A-$46.21M-31.61%$68.04M2.05$128.55M-2.67
GRTS
GRITSTONE BIO INC
$0.87N/AN/A-0.73x-0.67x6.20x1.65xN/A-$126.22M-125.06%$51.85M0.45$125.20M-1.11

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 4.87% over the past year, overperforming other biotech stocks by 26 percentage points.

Corcept Therapeutics has an average 1 year price target of $39.33, an upside of 64.71% from Corcept Therapeutics's current stock price of $23.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.73% over the past year, underperforming other biotech stocks by -9 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 41.52% from Incyte's current stock price of $52.94.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -93.23% over the past year, underperforming other biotech stocks by -72 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 469.95% from Amylyx Pharmaceuticals's current stock price of $1.93.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.06%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.44%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and up 3.18% over the last week. Cytomx Therapeutics was the among the top gainers in the biotechnology industry, gaining 214.72% yesterday.

CytomX Therapeutics shares are trading higher after the company announced that it will report Q1 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.73% in the past year. It has underperformed other stocks in the biotech industry by -9 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.55% in the past year. It has performed in line with other stocks in the biotech industry.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -93.23% in the past year. It has underperformed other stocks in the biotech industry by -72 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 84.82% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 7.71x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.